DA32 Life Science Tech Acquisition Corp. (DALS) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 12 transactions totaling $62.5M, demonstrating a bullish sentiment with $62.5M in net insider flow. The most recent transaction on Jul 28, 2023 involved a transaction of 1,600,000 shares valued at $0.
No significant insider buying has been recorded for DALS in the recent period.
No significant insider selling has been recorded for DALS in the recent period.
Based on recent SEC filings, insider sentiment for DALS is bullish with an Insider Alignment Score of 100/100 and a net flow of $62.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at DA32 Life Science Tech Acquisition Corp. (DALS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading DALS stock, having executed 12 transactions in the past 90 days. The most active insider is Keith Crandell (Executive), who has made 3 transactions totaling $22.5M.
Get notified when executives and directors at DALS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 28, 2023 | E. Flynn James | Executive | Other | 1,600,000 | $N/A | $0 | |
| Jul 28, 2023 | Nelsen Robert | Executive | Other | 1,600,000 | $N/A | $0 | |
| Jul 28, 2023 | Crandell Keith | Executive | Other | 1,600,000 | $N/A | $0 | |
| Jul 30, 2021 | Llc Da32 Sponsor | Executive | Purchase | 650,000 | $10.00 | $6.5M | Large |
| Jul 30, 2021 | Company, L.p. (series C) Deerfield Management | Executive | Award | 650,000 | $10.00 | $6.5M | Large |
| Jul 30, 2021 | Company, L.p. (series C) Deerfield Management | Executive | Purchase | 1,600,000 | $10.00 | $16.0M | Large |
| Jul 30, 2021 | Partners Xi, L.p. Arch Venture | Executive | Other | 650,000 | $10.00 | $6.5M | Large |
| Jul 30, 2021 | Partners Xi, L.p. Arch Venture | Executive | Purchase | 1,600,000 | $10.00 | $16.0M | Large |
| Jul 30, 2021 | Crandell Keith | Executive | Award | 650,000 | $10.00 | $6.5M | Large |
| Jul 30, 2021 | Crandell Keith | Executive | Purchase | 1,600,000 | $10.00 | $16.0M | Large |
| Jul 30, 2021 | Fund 3, Lp Section 32 | Executive | Award | 650,000 | $10.00 | $6.5M | Large |
| Jul 30, 2021 | Fund 3, Lp Section 32 | Executive | Purchase | 800,000 | $10.00 | $8.0M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 5 | $62.5M | 70.6% |
Award(A) | 3 | $19.5M | 22.0% |
Other(J) | 4 | $6.5M | 7.3% |
Insiders at DA32 Life Science Tech Acquisition Corp. are accumulating shares at an accelerated pace. With 7 insiders making 12 transactions totaling $62.5M in purchases versus $0 in sales, the net buying activity of $62.5M signals strong executive confidence. Keith Crandell (Executive) leads the buying activity with $22.5M in transactions across all time.